“Prediction of Long-term Scalp Hair Regrowth at 24 Months in Patients with Alopecia Areata Receiving Ritlecitinib Treatment in the ALLEGRO Clinical Trial Program”, J of Skin, vol. 9, no. 2, p. s561, Mar. 2025, doi: 10.25251/skin.10.supp.561.